KBC Group NV

Position in NKTR — Nektar Therapeutics

CIK 1411133 Brussels, C9

Position in NKTR

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$81,468

+$29,593 QoQ

Shares Held

1,167

+61.9% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#197

of 240 holders

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

KBC Group NV holds $308,329,109 across 107 Biotechnology names. NKTR ranks #65 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	179,508	$111,930,417
2	VRTX	Vertex Pharmaceuticals Inc / Ma	128,466	$63,812,914
3	INCY	Incyte Corp	270,882	$30,707,183
4	JAZZ	Jazz Pharmaceuticals plc	98,265	$23,678,916
5	CORT	Corcept Therapeutics Inc	91,584	$7,963,228
6	XENE	Xenon Pharmaceuticals Inc.	129,010	$7,787,043
7	BMRN	Biomarin Pharmaceutical Inc	127,194	$7,278,040
8	CRSP	CRISPR Therapeutics AG	116,847	$6,372,835

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$81,468	1,167	+61.9%	Shares	Defined	2026-08-05
2026-03-31	$51,875	721	-95.6%	Shares	Defined	2026-05-07
2023-03-31	$11,363	16,233	0.0%	Shares	Defined	2024-02-14
2022-12-31	$36,686	16,233	0.0%	Shares	Defined	2024-02-14
2022-09-30	$51,945	16,233	0.0%	Shares	Defined	2024-02-15
2022-06-30	$61,685	16,233	+75.4%	Shares	Defined	2024-02-14
2022-03-31	$49,879	9,254	+8.0%	Shares	Defined	2024-02-14
2021-12-31	$115,807	8,572	+17.3%	Shares	Defined	2024-02-14
2021-09-30	$131,251	7,308	0.0%	Shares	Defined	2021-11-10
2021-06-30	$125,405	7,308	0.0%	Shares	Defined	2022-02-15
2021-03-31	$146,160	7,308	0.0%	Shares	Defined	2022-02-14
2020-12-31	$124,236	7,308	+31.6%	Shares	Defined	2022-02-14
2020-09-30	$92,157	5,555	-92.8%	Shares	Defined	2022-02-14
2020-06-30	$1,778,826	76,806	-78.6%	Shares	Defined	2022-02-14
2020-03-31	$6,399,849	358,535	—	Shares	Defined	2020-05-04
No filing history on record for this holder in this stock.